Detalles de la búsqueda
1.
Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer.
Future Oncol
; 16(12): 749-762, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32228198
2.
Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
Thorac Cardiovasc Surg
; 64(6): 501-6, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26322832
3.
Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy.
J Thorac Oncol
; 10(8): 1221-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26200278
4.
EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany: an observational study.
Cancer Epidemiol Biomarkers Prev
; 24(8): 1254-61, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26070531
5.
Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.
J Clin Oncol
; 31(19): 2404-12, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23690416
6.
Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study.
J Thorac Oncol
; 7(6): 1053-7, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22588156
Resultados
1 -
6
de 6
1
Próxima >
>>